Sick sense

Pierce, Julia
August 2003
Engineer (00137758);8/8/2003, Vol. 292 Issue 7633, p17
Reports on a pill able to deliver a patient-specific dose of medication being developed at the University of Calgary in Alberta. Benefits provided by the drug in terms of minimizing the side effects of medication taken by sufferers of diseases; Use of supercapacitators to power the pill; Encapsulation features of the drug.


Related Articles

  • INTRODUCTION.  // Electronic Ardell Wellness Report (E-AWR);8/8/2008, Issue 447, p1 

    The article discusses a report published within the issue on a fitness pill.

  • parvule.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1717 

    A definition of the term "parvule" which refers to a small pill, pellet or granule is presented.

  • New drugs and dosage forms.  // American Journal of Health-System Pharmacy;6/15/2009, Vol. 66 Issue 12, p1063 

    The article lists the new drugs and its dosage forms including Bromocriptine mesylate, Lamotrigine and Telbivudine.

  • New drugs and dosage forms.  // American Journal of Health-System Pharmacy;5/1/2010, Vol. 67 Issue 9, p690 

    The article presents the newly developed drugs and their dosage forms including the Adapalene lotion, the Doxepin tablets, and the Polidocanol injection.

  • PediaTrick.  // Pediatrics for Parents;2003, Vol. 20 Issue 10, p7 

    Offers tips on how to help children swallow medicines in the pill form. Advantages of the dunking the pills in a creamy salad dressing; Benefits of drinking a glass of cold liquid before swallowing the pill.

  • Annual cost for Polypill £ 1.2 billion claims GP.  // Pulse;11/17/2003, Vol. 63 Issue 46, p2 

    Reports that the Polypill, the drug being developed by the British government, can extend the average lifespan by about 10 years.

  • The magic pill for long life.  // South Asian Post;5/20/2010, p8 

    The article reports on the study which aims to develop a magic pill that will let people become healthy and survive beyond 100 years.

  • Multiple Sclerosis Update.  // PharmaWatch: CNS;Apr2007, Vol. 6 Issue 4, p7 

    The article offers news update related to the treatment of multiple sclerosis (MS). According to a study from researchers at the University of Calgary in Alberta, a hormone produced by women in pregnancy offers hope to MS patients. On the other hand, the Immune Response Corp. has injected the...

  • University of Calgary Signs Affiliation Agreement with the Centre for Drug R&D (CDRD) to Support Preclinical Drug Development.  // Biomedical Market Newsletter;5/9/2011, p200 

    The article reports on an affiliation agreement between the Centre for Drug R&D (CDRD), the University of Calgary and University Technologies International Inc. (UTI). CDRD's mission is to narrow the commercialization gap between drug discovery and private investment by offering resources to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics